Bath, United Kingdom, December 4th, 2024 – Stablepharma Ltd today announces it was named a Fierce Life Sciences Innovation Awards winner by Fierce Biotech and Fierce Pharma in the Biotech Innovation category. The awards program highlights and showcases outstanding innovation that is driving improvements and transforming the industry. “The Innovation Awards winners showcase the organizations that have […]
Read More
Dr. Steven Chatfield appointed as Non-Executive Chairman of Stablepharma, following an extensive career in vaccine R&D and Covid19 Pandemic. Dr. Chatfield, who currently serves on Stablepharma’s Advisory Board, is taking on the role of Non-Executive Chairman of the company in November. He has been instrumental in advising and advancing the launch of SPVX02, a fridge-free […]
Read More
Stablepharma considers IPO, Series B round to bring vaccines to market – CEO 08:00 CEST, 5 April 2023 Stablepharma, a UK developer of the world’s first fridge-free vaccines, is evaluating an IPO and a financing round to bring two vaccines to market, CEO Özgür Tuncer told Mergermarket. The business will take a decision after the summer […]
Read More